We examined the membrane expression of inducible Hsp70 and HSP receptors like TLR2, TLR4, CD14, CD36, CD40 and CD91 on fibroblast-like synovial cells (SC) derived from synovial tissue in 23 patients with rheumatoid arthritis (RA), who underwent synovectomy by using flow cytometric analysis. For comparison, autologous skin fibroblasts (SF) derived from the operation wound were tested. Significantly higher Hsp70 expression was found on synovial cells than on skin fibroblasts (median SC 21.4% x SF 5.0%, P < 0.001). Both synovial cells and skin fibroblasts expressed high levels of cell surface CD91 (median SC 80.2% x SF 79.2%), however, no or low levels of CD14, CD40, TLR2, TLR4 and CD36. Further, we observed high co-expression of CD91 and Hsp70 on RA synovial cells (median 18.6%), while skin fibroblasts showed only background Hsp70 expression (median 3.9%, P < 0.001). Since we demonstrated the high prevalence of inducible Hsp70 in RA synovial fluids, we speculate that Hsp70 might be captured onto the membrane of synovial cells from the extracellular space via the CD91 receptor. The significance of the Hsp70 interaction with synovial cells via CD91 remains undefined, but may mediate other non-immune purposes.

Department of Molecular Biology and Cell Pathology 3rd Medical Faculty Charles University Ruska 87 Prague 10 10000 Czech Republic

Zobrazit více v PubMed

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6128-33 PubMed

Arthritis Res. 2000;2(5):344-7 PubMed

J Cell Sci. 1994 Aug;107 ( Pt 8):2285-9 PubMed

J Immunol. 2003 Dec 1;171(11):5736-42 PubMed

J Autoimmun. 2006 Sep;27(2):81-8 PubMed

Melanoma Res. 2003 Apr;13(2):147-52 PubMed

Arthritis Rheum. 1994 Nov;37(11):1664-71 PubMed

Immunity. 2001 Mar;14(3):303-13 PubMed

Arthritis Rheum. 1988 Mar;31(3):315-24 PubMed

J Cell Biol. 2002 Sep 30;158(7):1277-85 PubMed

Nat Med. 1996 Mar;2(3):306-10 PubMed

J Rheumatol. 1988 Jan;15(1):10-6 PubMed

Proc Natl Acad Sci U S A. 2005 May 31;102(22):7922-7 PubMed

Arthritis Res. 2001;3(2):80-6 PubMed

FEBS Lett. 2005 Mar 28;579(9):1951-60 PubMed

J Immunol. 2002 Mar 15;168(6):2997-3003 PubMed

FASEB J. 1999 May;13(8):833-42 PubMed

Lab Invest. 1995 Feb;72(2):209-14 PubMed

Tissue Antigens. 2004 Oct;64(4):442-51 PubMed

J Biol Chem. 2000 Jun 2;275(22):17187-94 PubMed

Eur J Immunol. 2002 Feb;32(2):322-32 PubMed

J Mol Med (Berl). 2006 Oct;84(10):821-32 PubMed

Ann Rheum Dis. 2004 Jul;63(7):774-84 PubMed

EMBO J. 2003 Nov 17;22(22):6127-36 PubMed

Rheumatol Int. 2006 Jan;26(3):244-51 PubMed

Scand J Rheumatol. 2006 Nov-Dec;35(6):447-53 PubMed

Immunity. 2001 Dec;15(6):971-83 PubMed

Immunogenetics. 2002 May;54(2):67-73 PubMed

Am J Pathol. 2003 May;162(5):1549-57 PubMed

J Rheumatol. 1997 Mar;24(3):430-5 PubMed

Curr Opin Immunol. 2002 Feb;14(1):45-51 PubMed

Methods. 2007 Nov;43(3):199-206 PubMed

FEBS Lett. 2007 Jul 31;581(19):3689-94 PubMed

Cell Stress Chaperones. 2000 Nov;5(5):425-31 PubMed

J Immunol. 2004 Oct 15;173(8):5130-7 PubMed

Nat Med. 2000 Apr;6(4):435-42 PubMed

J Clin Invest. 1998 Jul 15;102(2):302-11 PubMed

Ann Rheum Dis. 1996 Jul;55(7):442-9 PubMed

Brain Res. 2001 Sep 28;914(1-2):66-73 PubMed

Immunity. 2002 Sep;17(3):353-62 PubMed

Eur J Immunol. 2007 Apr;37(4):1053-63 PubMed

J Biol Chem. 2002 Apr 26;277(17):15028-34 PubMed

Biol Chem. 2003 Feb;384(2):267-79 PubMed

Mol Cell Biol. 1997 Sep;17(9):5317-27 PubMed